Latest Breaking News On - Symbiosis society - Page 6 : vimarsana.com

Mumbai: Pune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies likely to file its draft red herring prospectus (DRHP) with the market regulator SEBI next week for Rs 4,000 crore initial public offering (IPO), people aware of the matter told ET. The IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired about 13 per cent stake in the company seven years back. While the company is looking to dilute up to a 20 per cent stake, its existing investor Bain Capital aims to exit its entire holdings of 13 per cent, said sources.

Jammu and kashmirNew yorkUnited statesAndhra pradeshHong kongHan iRepublic ofEmcure pharmaVidya yeravdekarBerjis desaiShailesh ayyangarSatish mehtaHitesh jainVijay gokhaleEmcure pharmaceuticalsIndian foreign service